Breast Reduction — How It Works, Benefits & Recovery — Procedure Guide, Recovery & Risks | MyMedicPlus

Breast reduction (reduction mammoplasty) is a surgical procedure to remove excess breast tissue, fat, and skin, achieving a breast size proportionate to the patient's body frame. It is one of the most functionally effective plastic surgical procedures and consistently achieves among the highest patient satisfaction rates in surgery. Beyond cosmetic improvement, reduction mammoplasty is a functionally indicated operation for symptomatic macromastia — disproportionately large breasts causing measurable physical and psychological disability. The procedure simultaneously reduces breast volume, repositions the nipple-areola complex (NAC) at a higher, more youthful position, and reshapes breast contour. Performed by plastic surgeons, it is classified as both a reconstructive and cosmetic procedure depending on the indication. Breast reduction (reduction mammoplasty) is a surgical procedure to remove excess breast tissue, fat, and skin, achieving a breast size proportionate to the patient's body frame. It is one of the most patient-satisfaction-effective operations in plastic surgery, consistently delivering relief of physical symptoms (neck, shoulder, and back pain; intertrigo; bra strap grooving) and significant improvements in quality of life, self-image, and physical activity capacity. Macromastia (abnormally large breasts) affects an estimated 1 in 500 women of reproductive age sufficiently to impair daily function. Breast reduction is performed by plastic surgeons. In many countries, breast reduction that corrects documented physical symptoms and removes a minimum tissue weight (usually 500 g per side) is covered by public or private health insurance. The procedure permanently reduces breast size, and results are long-lasting, though future pregnancies and weight gain can affect breast volume.

Reduction mammoplasty is indicated for women with symptomatic macromastia causing: chronic neck, shoulder, or upper back pain due to bra strap tension; thoracic kyphosis (postural change from breast weight); intertriginous skin rashes (intertrigo) in the inframammary fold; paraesthesiae (numbness/tingling) in the ulnar nerve distribution of the hands from shoulder girdle pressure; inability to participate in physical exercise; and significant psychological distress, including body dysmorphia and social withdrawal related to breast size. Patients should be at or near their target weight (BMI ideally under 35) and non-smokers or have quit smoking 4–6 weeks pre-operatively. NHS (UK) criteria require documented physical symptoms with failed conservative management (physiotherapy, weight loss, proper bra fitting). Reduction mammoplasty is indicated for women with symptomatic macromastia causing chronic neck, shoulder, or upper back pain attributable to bra strap tension; thoracic kyphosis (postural change from breast weight); chronic intertrigo (inframammary skin irritation and fungal infection); physical limitation in sports, exercise, and daily activities; or significant psychological distress about breast size. Physical examination must confirm that breast weight is contributing to musculoskeletal symptoms. Bra strap grooving of the shoulder skin and forward head posture support a functional indication. Body mass index should ideally be below 35 kg/m² to reduce anaesthetic and wound healing risks. Patients should be over 18 and breast development complete. Smokers must stop at least 4–6 weeks before surgery to reduce the risk of nipple-areola ischaemia and wound healing complications, which are significantly elevated in smokers. Patients planning future pregnancies are counselled that the surgery may reduce breastfeeding capacity.

Under general anaesthesia, the most commonly used technique is the inferior pedicle with inverted-T (Wise pattern) scar, which provides reliable NAC blood supply and consistent shape for larger reductions. The vertical scar (Lejour or Hall-Findlay) technique creates a lollipop-shaped scar and is preferred for moderate reductions, producing better long-term shape with less scar. The surgeon removes excess breast tissue, fat, and skin, repositions the NAC to the correct height (approximately 21–23 cm from the sternal notch), and reshapes the breast mound. Closed suction drains are placed and removed within 24–48 hours. Liposuction alone is occasionally used for patients wanting only volume reduction without significant ptosis (sagging) correction. Under general anaesthesia, the most widely used technique is the inferior pedicle with inverted-T (Wise pattern) scar, which provides reliable NAC blood supply and consistent shape for larger reductions. Pre-operative markings define the new NAC position, skin excision pattern, and amount of tissue to remove. The NAC is elevated on its pedicle, excess breast parenchyma is excised from the medial, lateral, and superior poles, and the remaining breast tissue is shaped into a projecting cone. The skin envelope is tailored and closed in three layers — a periareolar scar around the NAC, a vertical scar from the areola to the IMF, and a horizontal scar in the IMF crease (the 'anchor' pattern). Superior pedicle techniques (vertical scar reduction, Hall-Findlay technique) minimise the horizontal scar for smaller reductions. Liposuction alone may be used in patients with primarily fatty macromastia and minimal skin excess. Surgical drains may be placed and removed after 24–48 hours. Tissue is sent for histopathological examination.

Breast reduction achieves among the highest patient satisfaction rates in plastic surgery — exceeding 95% in multiple prospective studies. Relief of neck, back, and shoulder pain is immediate and sustained in over 90% of patients, often reducing or eliminating analgesic requirements. Intertrigo resolves completely in nearly all patients. Physical activity capacity improves significantly within 6–8 weeks. A NICE review concluded that breast reduction for macromastia is clinically effective and cost-effective. Long-term psychological outcomes show sustained improvement in body image, self-esteem, and social functioning. The aesthetic result continues to improve for 12 months as scars mature and swelling fully resolves. Breast reduction achieves among the highest patient satisfaction rates in plastic surgery — exceeding 95% in multiple prospective studies. Relief of neck, back, and shoulder pain is immediate and sustained at long-term follow-up (5–10 years), with significant reductions in analgesic use reported. Skin intertrigo resolves completely in nearly all patients. Physical fitness and participation in sports increase substantially after reduction. Multiple BREAST-Q (validated patient-reported outcome) studies confirm large improvements in psychosocial wellbeing, sexual wellbeing, and satisfaction with breast appearance. Bra size reduction of 2–4 cup sizes or more is typical. Patients report improved sleep quality, reduced bra-strap grooving, and ability to participate in activities previously limited by breast size.

Scarring is the most accepted trade-off — scars are permanent but fade significantly over 12–18 months. Asymmetry (minor differences between breasts) affects 5–10% of patients. Changes in nipple or breast sensation (reduced or altered) affect 10–20% of patients; permanent complete loss is rare (under 2%). Fat necrosis (firm lumps from poor tissue healing) occurs in 2–5% and usually resolves spontaneously. Wound healing problems are more common in smokers, diabetics, and women with BMI over 35. Haematoma requiring evacuation occurs in 1–2%. Breastfeeding capacity is reduced in many patients as milk ducts may be divided, though some women successfully breastfeed after vertical-scar techniques that better preserve ductal architecture. Scarring is the most accepted trade-off of breast reduction — scars are permanent but fade significantly over 12–18 months and are typically concealed by bras and swimwear. Changes in nipple or breast sensation occur in 10–20% of patients transiently and permanently in 5–10%. Nipple-areola ischaemia and partial or total NAC loss (most serious complication) occurs in less than 1% with inferior pedicle technique but is significantly elevated in smokers, diabetics, and very large reductions requiring long pedicle lengths. Fat necrosis (localised areas of firmness) occurs in 3–5% and usually resolves spontaneously. Asymmetry (minor differences between breasts) affects 5–10% and may require secondary revision. Haematoma occurs in 1–2% and seroma in 3–5%, both typically managed conservatively. Wound infection is uncommon (1–2%) and treated with antibiotics. Delayed wound healing at the T-junction of the anchor scar occurs more frequently in patients with compromised blood supply.

Patients are discharged after 1–2 days. A surgical bra providing firm support is worn continuously for 6 weeks. Swelling peaks at days 3–5, then gradually resolves over 3–6 months. Showering is permitted after drain removal (24–48 hours). Desk work and light activities resume at 2 weeks; lifting anything over 2 kg and strenuous exercise are avoided for 4–6 weeks. Driving resumes when the patient can perform an emergency stop without discomfort, typically 2–3 weeks post-surgery. Scar maturation takes 12–18 months; silicone gel sheets or strips applied from 3 weeks optimise scar quality. Final results including optimal breast shape and scar quality are fully apparent at 12 months. Patients are discharged after 1–2 days with drain removal before discharge or at a 24–48 hour clinic review. A surgical bra providing firm support is worn continuously for 6 weeks. Swelling peaks at days 3–5 and gradually resolves over 3–6 months, with final shape apparent at 6–12 months. Showering is permitted after 48 hours with gentle wound drying. Driving is restricted for 2 weeks; desk work may resume at 2–3 weeks; light exercise at 4 weeks; and strenuous exercise and contact sports after 6 weeks. Scar management (silicone gel sheets or cream applied twice daily from week 3) improves scar quality over 12 months. Follow-up appointments are scheduled at 2 weeks, 6 weeks, and 3–6 months. Breastfeeding capacity may be reduced but is not invariably lost — patients planning future pregnancy are informed that lactation outcomes depend on pedicle type and amount of glandular tissue preserved.